Dr. Mark E. Gerich, MD

Dr. Gerich practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Gerich's NPI, 1578549754, was assigned on December 19, 2005. Dr. Gerich holds Colorado license 45844.

Dr. Gerich's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Gerich's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Gerich is also affiliated with UCHealth Highlands Ranch Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Gerich to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gerich practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gerich's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gerich is licensed in Colorado.

CMS data shows 204 Medicare services from Dr. Gerich across 8 procedure codes in 2024, for 204 Medicare patients. Medicare paid $27,286 for them.

CMS counts 204 Medicare patients who saw Dr. Gerich in 2024. The largest group is 65 to 74, with 126 patients. 64% of them have high cholesterol, and 59% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gerich's median patient age at 58, with 45% women.

In 2024, Dr. Gerich wrote 396 Medicare Part D claims for 201 patients. 67% of them were for generic drugs. CMS names the drug for 297 of them, across 11 drugs with 11 or more claims each, at $1,092,004 in total drug cost. In 2023, CMS named 265 claims across 11 drugs.

Dr. Gerich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gerich as offering telehealth. CMS counts 81 procedures of colonoscopy by Dr. Gerich, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 33 papers to Dr. Gerich, published from 2011 to 2024. 2016 was the busiest year, with 3. The most frequent topics are Colitis, Crohn Disease and Disease Models, Animal. Dr. Gerich has published most often in Inflamm Bowel Dis. Dr. Gerich's most frequent co-authors are Blair P. Fennimore, MD, Robert William Isfort, MD and Emilie Helen Regner, MD.

Dmand AI links Dr. Gerich to 7 clinical trials. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Gerich that name 2 trials.

CMS Open Payments shows 37 general payments to Dr. Gerich from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Merck Sharp & Dohme Corporation paid the most, $6,009. It also lists 4 research payments totaling $4,996 from 2016 to 2017, naming 2 clinical trials.